DETERMINATION OF ROBUST OCULAR PHARMACOKINETIC PARAMETERS IN SERUM AND VITREOUS-HUMOR OF ALBINO RABBITS FOLLOWING SYSTEMIC ADMINISTRATION OF CIPROFLOXACIN FROM SPARSE DATA SETS BY USING IT2S, A POPULATION PHARMACOKINETIC MODELING PROGRAM

被引:20
作者
DRUSANO, GL
LIU, WG
PERKINS, R
MADU, A
MADU, C
MAYERS, M
MILLER, MH
机构
[1] ALBANY MED COLL,DEPT PHARMACOL,ALBANY,NY 12208
[2] ALBANY MED COLL,DIV CLIN PHARMACOL,ALBANY,NY 12208
[3] ALBANY MED COLL,DIV INFECT DIS,ALBANY,NY 12208
[4] ALBERT EINSTEIN COLL MED,DEPT OPHTHALMOL,BRONX,NY 10467
[5] PACE UNIV,DEPT MANAGEMENT SCI,NEW YORK,NY 10038
关键词
D O I
10.1128/AAC.39.8.1683
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Robust determination of the concentration-time profile of anti-infective agents in certain specialized compartments is often limited by the inability to obtain more than a single sample from such a site in any one subject, Vitreous humor and cerebrospinal fluid are obvious examples for which the determination of concentrations of anti-infective agents is limited, Advances in pharmacodynamics have pointed out the importance of understanding the profiles of drugs in the plasma and in specialized compartments in order to dose the drugs to obtain the best patient outcomes, Advances in population pharmacokinetic modeling hold the promise of allowing proper estimation of drug penetration into the vitreous (dr other specialized compartment) with only a single vitreous sample, in conjunction with plasma sampling. We have developed a rabbit model which allows multiple samples of vitreous to be obtained without breaking down the blood-vitreous barrier. We have employed this model to test the hypothesis that robust estimates of vitreous penetration by the fluoroquinolone ciprofloxacin can be obtained from a traditional intensive plasma sampling set plus a single vitreous sample. We studied 33 rabbits which were receiving 40 mg of ciprofloxacin per kg of body weight intravenously as short infusions and from which multiple plasma and vitreous samples were obtained and assayed for ciprofloxacin content by high-performance liquid chromatography. Data were analyzed by the iterative two-stage population modeling technique (IT2S), employing the iterative two-stage program of Forrest et al, (Antimicrob. Agents Chemother. 37:1065-1072, 1993). Two data sets were analyzed: all plasma and vitreous samples versus all plasma samples and the initially obtained single vitreous sample, The pharmacokinetic parameter values identified were used to calculate the percent vitreous penetration as the ratio of the area under the concentration-time curve for the vitreous to that for the plasma, The values identified, 4% penetration for the full data set versus 3% penetration for the single vitreous sample data set, and their corresponding estimates were not statistically significantly different. We conclude that population modeling holds promise for the analysis of penetration of antimicrobial agents into specialized spaces from which only single samples can be obtained, particularly for patients with whom robust plasma sampling can be performed.
引用
收藏
页码:1683 / 1687
页数:5
相关论文
共 18 条
  • [1] GENERAL-PRINCIPLES OF ANTIBIOTIC TISSUE PENETRATION
    BARZA, M
    CUCHURAL, G
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1985, 15 : 59 - 75
  • [2] COMPARATIVE-STUDY WITH ENOXACIN AND NETILMICIN IN A PHARMACODYNAMIC MODEL TO DETERMINE IMPORTANCE OF RATIO OF ANTIBIOTIC PEAK CONCENTRATION TO MIC FOR BACTERICIDAL ACTIVITY AND EMERGENCE OF RESISTANCE
    BLASER, J
    STONE, BB
    GRONER, MC
    ZINNER, SH
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1987, 31 (07) : 1054 - 1060
  • [3] DARGENIO DZ, 1992, ADAPT 2 USERS MANUAL
  • [4] ROLE OF PHARMACOKINETICS IN THE OUTCOME OF INFECTIONS
    DRUSANO, GL
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1988, 32 (03) : 289 - 297
  • [5] PHARMACODYNAMICS OF A FLUOROQUINOLONE ANTIMICROBIAL AGENT IN A NEUTROPENIC RAT MODEL OF PSEUDOMONAS SEPSIS
    DRUSANO, GL
    JOHNSON, DE
    ROSEN, M
    STANDIFORD, HC
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (03) : 483 - 490
  • [6] DEVELOPMENT OF A POPULATION PHARMACOKINETIC MODEL AND OPTIMAL SAMPLING STRATEGIES FOR INTRAVENOUS CIPROFLOXACIN
    FORREST, A
    BALLOW, CH
    NIX, DE
    BIRMINGHAM, MC
    SCHENTAG, JJ
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (05) : 1065 - 1072
  • [7] PHARMACODYNAMICS OF INTRAVENOUS CIPROFLOXACIN IN SERIOUSLY ILL-PATIENTS
    FORREST, A
    NIX, DE
    BALLOW, CH
    GOSS, TF
    BIRMINGHAM, MC
    SCHENTAG, JJ
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (05) : 1073 - 1081
  • [8] DETERMINATION OF CIPROFLOXACIN (BAY O 9867) IN BIOLOGICAL-FLUIDS BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY
    GAU, W
    PLOSCHKE, HJ
    SCHMIDT, K
    WEBER, B
    [J]. JOURNAL OF LIQUID CHROMATOGRAPHY, 1985, 8 (03): : 485 - 497
  • [9] COMPARATIVE ANTIBIOTIC DOSE-EFFECT RELATIONS AT SEVERAL DOSING INTERVALS IN MURINE PNEUMONITIS AND THIGH-INFECTION MODELS
    LEGGETT, JE
    FANTIN, B
    EBERT, S
    TOTSUKA, K
    VOGELMAN, B
    CALAME, W
    MATTIE, H
    CRAIG, WA
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1989, 159 (02) : 281 - 292
  • [10] LIU W, 1994, INVEST OPHTH VIS SCI, V35, P2216